Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02383966 |
|---|---|
| Brief Title: | Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer (CHANGE2) |
| First Submitted : | March 4, 2015 |
| First Submitted that Met QC Criteria : | March 4, 2015 |
| First Posted : | March 10, 2015 (Estimate) |
| Results First Submitted : | January 18, 2019 |
| Results First Submitted that Met QC Criteria : | January 18, 2019 |
| Results First Posted : | April 16, 2019 |
| Last Update Submitted that Met QC Criteria : | April 19, 2022 |
| Last Update Posted : | May 13, 2022 |